phv00090199.v1 ::: Age at time of dental exam 
phv00102450.v1 ::: SPECIFY OTHER REASON GTT NOT DONE 
phv00030904.v1 ::: Corrective lenses obtained by subjective refraction for distance (indicate if plus [+] or minus [-] were used): cylinder - left eye 
phv00003217.v1 ::: ECG: NON-SPECIFIC S-T SEGMENT ABNORMALITY 
phv00000861.v1 ::: X-RAY: AORTA TORTUOUS, DESCENDING, EXAM 6 
phv00142448.v1 ::: Vertebral Thoracic Level 11 Reading for Follow-up X-ray 
phv00098453.v1 ::: Mother's age at OGTT 
phv00032224.v1 ::: WAIS  information: total number of correct responses 
phv00023346.v3 ::: LEAD V3, Q  WAVE VOLTAGE 
phv00050668.v1 ::: B8g. Health care delivery. Chest x-ray: seen past 6 months 
phv00065362.v2 ::: WHOLEBODY LUMBAR BMD EX23 (GRAMS/CM2) 
phv00001503.v1 ::: BREAST EXAMINATION: AXILLARY NODES 
phv00051567.v1 ::: D1d. Post mortem information and diagnosis. Reason autopsy was not performed 
phv00030997.v1 ::: CBL9: GFR gamma count serum - pre-injection 
phv00106944.v1 ::: WAS GRIP STRENGTH TEST DONE 
phv00008664.v3 ::: ECG: R PLUS S GREATER THAN OR EQUAL TO 35 MM IN PRECORDIAL LEAD LVH CRITERIA 
phv00161432.v1 ::: Historic (estimated) glomerular filtration rate 
phv00023357.v3 ::: LEAD V4, R  WAVE VOLTAGE 
phv00155327.v2 ::: QRS deflection balance (maximum of R or R') + (maximum of QAMP, SAMP, or S'AMP), lead qrsd_avf 
phv00123704.v1 ::: ECG: II: STM 
phv00161225.v1 ::: Total QRS Area, Lead I (uVmSec) 
phv00020602.v1 ::: Inventory of Depression Severity (IDS) depression item 21: Feeling slowed down 
phv00023344.v3 ::: LEAD V2, QRS AREA WAVE VOLTAGE 
phv00023442.v3 ::: LEAD V1, S  WAVE DURATION 
phv00028517.v1 ::: CBL7: GFR gamma count urine - background 
phv00008121.v3 ::: ECG: STUDY 
phv00117951.v2 ::: CAT SCAN SINCE LST CARDIA XM - MON 96 
phv00006690.v1 ::: MMSE: OTHER (OTHER THAN THOSE LISTED ABOVE) (FACTORS POTENTIALLY AFFECTING MENTAL STATUS) 
phv00111389.v2 ::: Positive exercise test 
phv00071256.v2 ::: No. of core skin tests (all tests) at Follow-up 
phv00170104.v1 ::: CHF Pulmonary edema chest X-ray this admit 
phv00027364.v1 ::: CBL2: Repeat evaluation for GFR tests 
phv00154935.v2 ::: P wave area, lead bpa_i 
phv00072641.v2 ::: If no (0) or partial (2) to PDONE: PAT scan deviation was caused by an other problem. 
phv00009028.v3 ::: ECG DONE 
phv00092252.v1 ::: Bleeding on Probing (BL) measure for Mesiolingual (ML) of tooth number 32 
phv00050143.v1 ::: C1b. Neuropathy screening instrument: appearance of feet (right) deformities 
phv00123696.v1 ::: ECG: II: RA 
phv00071944.v1 ::: Test date - doppler ultrasound 
phv00031578.v1 ::: CBL4: Repeat evaluation for GFR tests 
phv00128210.v1 ::: BEST_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the best curve: measured in liters 
phv00106680.v1 ::: DEPRESSION SCALE TOTAL 
phv00000822.v1 ::: ECG: ARRHYTHMIA, EXAM 5 
phv00072351.v2 ::: REASON POST BRONCHODILATOR SPIROMETRY NOT DONE 
phv00070970.v1 ::: Baseline FEV1 PC20 methacholine 
phv00121709.v1 ::: STATUS OF ECG'S 
phv00121334.v2 ::: PAD BASED ON POS EXERCISE TEST 
phv00004002.v1 ::: ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) 
phv00001427.v1 ::: X-RAY: (AFTER) RIGHT VENTRICULAR HYPERTROPHY 
phv00001009.v1 ::: ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 7 
phv00007498.v1 ::: ECG LVH: R > 11 MM IN AVL 
phv00127310.v1 ::: QRS_V4 - QRS- Amplitude in lead V4 
phv00084550.v2 ::: MINOR Q, QS WAVES WITH ST-T ABNORMALITIES 
phv00093654.v1 ::: ST SEG ELEV (92X) V1-V5      - FUP ECG 
phv00008675.v3 ::: ECG: CLINICAL READING 
phv00161214.v1 ::: Special T Wave Amplitude = the Minimum of either T Amplitude or the T Amplitude - STE. Lead II (uV) 
phv00001428.v1 ::: X-RAY: (AFTER) ABNORMAL CONTOUR OTHER THAN ENLARGEMENT 
phv00049744.v1 ::: F. Ophthalmoscopic examination: why do you not plan photocoagulation in the eye(s) with high risk characteristics? Unable to laser left eye - other reason 
phv00034560.v1 ::: MNSI (Michigan Neuropathy Screening Instrument): patient score > 6 
phv00089404.v1 ::: Date of MRI, 1st MRI 
phv00009058.v3 ::: ECG: ST DEPRESSION 
phv00030383.v1 ::: CBL3: GFR gamma count serum - t1 
phv00161738.v1 ::: Spine at L2 bone mineral density 
phv00118863.v2 ::: FORCED VITAL CAPACITY, TRIAL #3 
phv00005871.v1 ::: ECG: VENTRICULAR PREMATURE BEATS 
phv00023355.v3 ::: LEAD V3, R WAVE NTCH WV VOLTAGE 
phv00064617.v2 ::: CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 
phv00001674.v1 ::: RESPIRATORY SYSTEM EXAMINATION: ABNORMAL BREATH SOUNDS 
phv00161067.v1 ::: T Wave Area, Lead AVR (uVmSec) 
phv00161215.v1 ::: Special T Wave Amplitude = the Minimum of either T Amplitude or the T Amplitude - STE. Lead III (uV) 
phv00101714.v1 ::: WAS GRIP STRENGTH TEST DONE 
phv00123616.v1 ::: ECG: V4: RA 
phv00095614.v1 ::: FEV(6) (liters) 
phv00002936.v1 ::: ECG: VPD DURING EXERCISE (ALL VALUES MISSING, DATA NOT MEASURED IN CORE EXAM) 
phv00110305.v1 ::: 2ND GRIP STRENGTH (2) KG 
phv00081126.v1 ::: If other autopsy result - specify 
phv00021166.v4 ::: ECG: NUMBER OF VENTRICULAR PREMATURE BEATS IN 
phv00000991.v1 ::: CHEST EXAMINATION: SCOLIOSIS, EXAM 7 
phv00114706.v2 ::: RATIO OF MAXIMUM FEV1 TO FVC 
phv00169395.v1 ::: FEV6 pre-bronch 
phv00159856.v2 ::: Pre/Post-bronch FEV1 volume change 
phv00090355.v2 ::: Date of CT Scan 
phv00001986.v1 ::: ECG: ATRIOVENTRICULAR BLOCK-INCOMPLETE 
phv00050190.v1 ::: C1b. Neuropathy screening instrument: appearance of feet (left) fissure 
phv00087723.v1 ::: SPIROMETRY COMPLETED 
phv00164655.v1 ::: Digoxin, for EKG group 
phv00084567.v2 ::: QRS INTERVAL (MSEC) 
phv00048485.v1 ::: GFR (glomerular filtration rate) raw count: urine-t5 
phv00066811.v2 ::: MEAN OF THE AORTIC VALVE SCORE (FROM MULTIPLE OBSERVERS) - SECOND SCAN 
phv00072014.v1 ::: Date of ECG for first sleep study 
phv00005882.v1 ::: ECG: LEFT VENTRICULAR HYPERTROPHY CRITERIA S>=25MM, (R IN V5 OR V6) OR (S IN V1 OR V2) 
phv00055067.v1 ::: SLIT LAMP EXAM: LENS CHANGES: CORTICAL CUNEIFORM LENS CHANGES, O.D. 
phv00114704.v2 ::: REPRODUCIBILITY OF MAX FEV1 (VOLUME DIF) 
phv00021759.v3 ::: OTOSCOPIC CHECK 
phv00118899.v2 ::: FORCED VITAL CAPACITY, TRIAL #6 
phv00024684.v3 ::: VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 
phv00111954.v2 ::: UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION 
phv00017084.v1 ::: B5b. CAT scan. Head CAT scan? (Participants with European ancestry). DIGS4 
phv00000562.v1 ::: X-RAY: NON-CARDIOVASCULAR ABNORMALITIES, EXAM 2 
phv00048572.v1 ::: Q12. Physical examination, extremities and skin examinations: gangrene - right side 
phv00107324.v1 ::: PARTICIPANT POSITION FOR ECG 
phv00154573.v2 ::: Accept s3 Pre  % Pred FEV1 
phv00032293.v1 ::: WISC-R digit span: number of points 
phv00099670.v1 ::: FVC PREDICTED VALUE 
phv00123666.v1 ::: ECG: I: SA 
phv00127302.v1 ::: QRS_II - QRS- Amplitude in lead II 
phv00148459.v1 ::: EXAM 4 CT SCANNER MODEL 
phv00127306.v1 ::: QRS_AVF - QRS- Amplitude in lead AVF 
phv00009491.v3 ::: ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) 
phv00169310.v1 ::: CT finding: bronchial wall thickening 
phv00155226.v2 ::: P wave amplitude, lead pam_avr 
phv00001496.v1 ::: HEART EXAMINATION: ANY MURMUR SIGNIFICANT 
phv00002761.v1 ::: BREAST EXAMINATION: LOCALIZED MASS 
phv00083501.v1 ::: OTHER SPECIFIC REASON SPIROMETRY NOT COMPLETED 
phv00006218.v1 ::: ECG - Q-T INTERVAL (HUNDREDTHS OF SECOND) 
phv00008141.v3 ::: ECG: OTHER FINDING 
phv00102688.v1 ::: CORONARY ANGIOGRAPHY, HEART CATH. 
phv00123698.v1 ::: ECG: II: SA 
phv00155563.v2 ::: T Wave Amplitude, Lead I (uV) 
phv00001306.v1 ::: BREAST EXAMINATION:  SCAR PRESENT 
phv00156579.v1 ::: Histological diagnosis 
phv00142442.v1 ::: Vertebral Thoracic Level 8 Reading for Follow-up X-ray 
phv00113297.v2 ::: FEV1/FVC, TRIAL 4 
phv00004449.v1 ::: ECG: R > 11 MM AV LEAD 
phv00071020.v1 ::: FVC at follow-up visit 
phv00065358.v2 ::: WHOLEBODY LUMBAR BMD EX22 (GRAMS/CM2) 
phv00002607.v1 ::: ECG: U-WAVE 
phv00032346.v1 ::: WISC-R block design: time needed to complete design  5 
phv00049839.v1 ::: E. Slit-lamp examination: right lens missing 
phv00101258.v1 ::: BL REREAD VESSEL MAX, L. POSTERIOR 
phv00010002.v3 ::: ECG DONE 
phv00123602.v1 ::: ECG: V3: SA 
phv00009489.v3 ::: ECG: VENTRICULAR RATE PER MINUTE 
phv00164039.v1 ::: Age in years at EKG measurement 
phv00121393.v2 ::: ICH BASED ON XANTHOCHROMIC SPINAL FLUID AND CEREBRAL ANGIOGRAPHY 
phv00114939.v2 ::: AUSCULTATORY/OSCILLOMETRIC ST1 
phv00024696.v3 ::: HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 
phv00072263.v2 ::: ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) 
phv00009488.v3 ::: ECG DONE 
phv00155291.v2 ::: Q wave amplitude, lead qam_avl 
phv00094241.v1 ::: ECHOCARDIOGRAM                       Q9A 
phv00001033.v1 ::: X-RAY: (BEFORE) HEART ENLARGEMENT, EXAM 7 
phv00123738.v1 ::: ECG: III: TA 
phv00116502.v2 ::: HIP: WARDS TRIANGLE BMD 
phv00155229.v2 ::: P wave amplitude, lead pam_iii 
phv00030424.v1 ::: CBL3: Glomerular filtration rate - 1st period 
phv00065306.v2 ::: WHOLEBODY ARM BMD EX23 (GRAMS/CM2) 
phv00027399.v1 ::: CBL2: Glomerular filtration rate - 1st period 
phv00093640.v1 ::: "I1":MAJOR Q V1-V5      - 1ST ECG 
phv00048515.v1 ::: GFR  (glomerular filtration rate) serum count diff: baseline to t-4 
phv00005231.v1 ::: ECG: VENTRICULAR RATE PER MINUTE 
phv00025375.v1 ::: Object assembly: age-corrected scaled score (WAIS for adults; WISC-R for adolescents; quarterly visit 28) 
phv00031000.v1 ::: CBL9: GFR gamma count serum - t2 
phv00155504.v2 ::: E (end of ST segment/beginning of T wave) amplitude, lead ste_v5 
phv00031725.v1 ::: CBL5: GFR gamma count urine - t3 
phv00004660.v1 ::: RECTAL EXAM - TEST FOR OCCULT BLOOD IN STOOL - PAST TWO YEARS 
phv00115622.v2 ::: RATIO FEV1/FVC, TRIAL #1 
phv00004903.v1 ::: ECG: LEFT VENTRICULAR HYPERTROPHY 
phv00010457.v3 ::: ECG LVH: MEASURED VOLTAGE R AVL IN MM (1 MV = 10 MM STANDARD) 
phv00155500.v2 ::: E (end of ST segment/beginning of T wave) amplitude, lead ste_v1 
phv00000571.v1 ::: ECG: MYOCARDIAL INFARCTION, EXAM 2 
phv00023303.v3 ::: LEAD AVR, T  WAVE VOLTAGE 
phv00000865.v1 ::: X-RAY: ARTHRITIS, GOUTY, EXAM 6 
phv00001983.v1 ::: ECG: INTRAVENTRICULAR BLOCK-LEFT 
phv00154619.v2 ::: Accept Annual Visit4 Post  % Pred FEV1 
phv00000683.v1 ::: HAND GRIP, EXAM 4 
phv00036357.v6 ::: PR INTERVAL CYCLE 1 LEAD II (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET) 
phv00070490.v1 ::: CORONARY ARTERIOGRAM (MOST RECENT ONLY) 
phv00159164.v2 ::: P Wave Area, Lead V3 (uVmSec) 
phv00009504.v3 ::: ECG: MYOCARDIAL INFARCT-ANTERIOR 
phv00077283.v1 ::: Cardiologist-generated free-text impression from first normal electrocardiogram 
phv00028780.v1 ::: Refraction performed for both eyes 
phv00072009.v1 ::: Nonspecific S-T abnormality for second sleep study 
phv00111296.v2 ::: ECG pattern 
phv00032376.v1 ::: Quality of neurobehavioral test: to what extent do you feel the information obtained is accurate? 
phv00023356.v3 ::: LEAD V4, Q  WAVE VOLTAGE 
phv00032237.v1 ::: WAIS  arithmetic: number of points 
phv00048530.v1 ::: GFR  (glomerular filtration rate) -log transf.-serum count diff (t-2-3) 
phv00024690.v3 ::: LDL PARTICLES 22+/-0.7 NM  (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 
phv00026519.v1 ::: CBL00: Glomerular filtration rate - 1st period 
phv00001989.v1 ::: ECG: PREMATURE BEATS 
phv00006225.v1 ::: ECG - HEMIBLOCK 
phv00022660.v1 ::: FORCED EXPIRATORY FLOW AFTER 50% OF THE FEV  HAS BEEN EXPIRED - SUMMARY 
phv00024978.v1 ::: Arithmetic: age-corrected score (WAIS for adults; WISC-R for adolescents at qv00) (quarterly visit 00) 
phv00155513.v2 ::: J (end of QRS) point amplitude, lead stj_v2 
phv00114695.v2 ::: MAXIMUM FEV1 
phv00003593.v1 ::: ECG: VENTRICULAR RATE 
phv00155533.v2 ::: T wave amplitude, lead tam_avr 
phv00001331.v1 ::: ECG:  ORS INTERVAL 
phv00020582.v1 ::: Inventory of Depression Severity (IDS) depression item 3: Waking up too early 
phv00116530.v2 ::: LATERAL: L3 BMD 
phv00034441.v1 ::: Examine for: left eye other fundoscopic abnormality 
phv00155355.v2 ::: Total QRS area, lead qrsr_ii 
phv00109317.v1 ::: QRS AXIS 
phv00010460.v3 ::: ECG LVH: R IN V5 OR V6: S IN V1 OR V2: S >= 25 MM 
phv00086619.v2 ::: LEAKAGE AT VENIPUNCTURE SITE 
phv00080620.v1 ::: Time from visit 1 to ultrasound scan in days 
phv00048543.v1 ::: GFR  (glomerular filtration rate) coefficient of variation 
phv00006344.v1 ::: FACTORS POTENTIALLY AFFECTING MENTAL STATUS TESTING: COMA 
phv00031058.v1 ::: CBL8: GFR gamma count urine - background 
